We experienced a case of adenocarcinoma arising in sacrococcygeal teratoma. The patient was a 52-year-old woman. She was admitted due to one month of sacral pain. She had a sacral mass since birth. On physical examination, anal fistula was present at the perianal area and pus drainage was noted. MR image showed multiple variable-sized cysts with inhomogeneous density. Resected specimen, mesuring 12.5 7.0 cm in diameter, showed multiple variable-sized cystic lesions admixed with grayish solid portion. The cysts contained mucoid material. The microscopic examination showed mature teratoma composed of cysts lined by pseudostratified ciliated columnar epithelium, intestinal mucosa, mature cartilage, bone, and fat tissue. A moderately differentiated adenocarcinoma developed from the cystic area in the mass.
Adenocarcinoma* ; Adult ; Cartilage ; Drainage ; Female ; Humans ; Intestinal Mucosa ; Middle Aged ; Mucous Membrane ; Parturition ; Physical Examination ; Rectal Fistula ; Suppuration ; Teratoma*

In the present study, immunohistochemical detection of p53 oncoprotein was performed to determine whether the grade of differentiation and the histologic type of gastric adenocarcinoma, and the degree of atypia accompanied with adenoma can be related to p53 mutation. Paraffin sections of 22 gastric adenomas and 56 gastric adenocarcinomas were examined for the overexpression of p53 oncoprotein with the avidin-biotin peroxidase complex staining procedure. The obtained results were as follows; 1. All the 22 cases of adenomas and 16 cases of well differentated adenocarcinomas showed uniformly negative staining. 2.Seven of 18 cases of moderately differentiated adenocarcinomas(39%), and five of 30 cases of poorly differentiated adenocarcinomas(17%) exhibited p53 protein expression. 3. Three of 29 cases of diffuse type (10%) and 9 of 19 cases of intestinal type(47%) exhibited p53 protein expression. These results suggest that p53 mutation is important in carcinogenesis of the intestinal type of gastric adenocarcinoma, and there is no correlation between the differentiation of gastric adenocarcinoma and the degree of p53 oncoprotein overexpression.
Adenocarcinoma ; Adenoma

BACKGROUND: The neuroprotective effects of 1,25-dihydroxyvitamin D3 on neurotoxicity have already been documented. However, the mechanisms underlying these effects are not fully understood. Extracellular signal-regulated kinase (ERK), one of the mitogen-activated protein kinases (MAPKs), is a serine-threonine kinase activated by phosphorylation in response to a variety of extracellular mitogenic or stress signals. The ERK signaling cascade plays an important role in the regulation of several cellular processes that include mainly proliferation, but differentiation, survival and ERK activation has also been linked to neuroprotection. We explored whether 1,25-dihydroxyvitamin D3 protects against kainic acid-induced toxiticy on neurons and, if so, whether the 1,25-dihydroxyvitamin D3 protection is mediated by ERK. METHODS: Experiments were carried out on Sprague-Dawley rats. Under anesthesia, a solution containing the drug being investigated (e.g. 1.25-dihydoxyvitamin D3) was stereotaxically infused into the hippocampus or ventricle. In the rat hippocampus, brain slices were stained with cresyl violet for the visualization of neuronal cell bodies and ERK phophorylation was assayed. RESULTS: The injection of kainic acid into the hippocampi of male rats produced a loss of cresyl violet-stained neurons. Pretreatment with U0126, an inhibitor of MAPK/ERK kinase, inhibited the rapid activation of ERK by 1,25-dihydroxyvitamin D3 in the rat hippocampus. Moreover, the neuroprotective effects of 1,25-dihydroxyvitamin D3 against kainic acid toxicity were blocked by the pretreatment with U0126. CONCLUSIONS: These results indicate that ERK mediates 1,25-dihydroxyvitamin D3 neuroprotection after kainic acid toxicity in the rat hippocampus.
Anesthesia ; Animals ; Brain ; Calcitriol ; Hippocampus* ; Humans ; Kainic Acid ; Male ; Mitogen-Activated Protein Kinases ; Neurons ; Neuroprotective Agents ; Phosphorylation ; Phosphotransferases ; Protein-Serine-Threonine Kinases ; Rats* ; Rats, Sprague-Dawley ; Viola

Tumorlet is a rare lesion of disputed origin that was first described by whitwell in 1955, and about one-third of the reported cases have been associated with underlying lung disease. Patient was a 60-year-old female who was admitted with a histroy of chest discomfort and dyspnea. Right lower lobe was partially resected under the clinical diagnosis of the bronchogenic cyst. Grossly, lung tissue around round cystic lesion appeared brown firm and somewhat fibrotic, and showed several scattered ill-defined whitish gray nodules. Microscopically, lung tissue around bronchogenic cyst was partially obliterated by dense fibrous scar tissue. Within this areas of fibrosis, and in the wall of alveolar ducts and respiratory bronchioles, innumerable microscopic tumorlets were found and argyrophilic granules were also demonstrated in scattered tumorlets with Grimelius stain.
Female ; Humans ; Cysts

PURPOSE: The insulin-like growth factor-I receptor (IGF-IR) is a member of the transmembrane tyrosine kinase family that regulates various biological processes. These processes include maintaining optimal cell growth, establishing and maintaining the transformed phenotype, tumorigenesis for several types of cells, and antiapoptosis. This study investigated the immunohistochemical expression of IGF-IR in relation with the expression of the estrogen receptor (ER), the progesteron receptor (PR), proliferative activity (Ki-67) as well as with the other conventional clinicopathlogical parameters in breast cancer. METHODS: This study was performed on paraffin sections from 64 invasive ductal breast carcinoma specimens by immunohistochemistry using rabbit polyclonal antibodies to the IGF-I receptor. RESULTS: IGF-IR expression was detected in 56 (87.5%) cases. The immunohistochemical stains for the IGF-IR were scored according to a semi quantitative scoring system. IGF-IR staining was positively correlated with the ER status, but not significantly with the PR, lymph node status, tumor size, histological grade, and proliferative activity. The Ki-67 labeling index showed a significant correlation with the tumor grade and ER status. CONCLUSION: The IGF-IR may play a role in estrogen-mediated growth and the pathogenesis of breast cancer.
Antibodies ; Biological Processes ; Breast Neoplasms ; Breast* ; Carcinogenesis ; Carcinoma, Ductal* ; Coloring Agents ; Estrogens ; Humans ; Immunohistochemistry ; Lymph Nodes ; Paraffin ; Phenotype ; Protein-Tyrosine Kinases ; Receptor, IGF Type 1

OBJECTIVES: Hemophilia B has been known to result from more than 500 kinds of mutations. And it is difficult to find out a mutation specific for each family. Therefore, linkage analysis of DNA polymorphism within or near the factor IX gene has been frequently used in the clinical practice for molecular genetic diagnosis of hemophilia B. But the ethnic variation makes more difficult to apply useful markers in Caucasian population. To investigate the usefulness of the MseI and HhaI polymorphism in Korean population, we analysed the MseI and HhaI polymorphism. METHODS: Forty-five normal Korean and thirteen parents of the hemophilia B patients, using PCR and restriction enzyme analysis. RESULTS: The heterozygosity rate of MseI polymorphism was 49.7% and that of HhaI polymorphism was 25.5%. CONCLUSION: These data indicated that PCR-based analysis of MseI and HhaI polymorphism of factor IX was useful in molecular genetic diagnosis of hemophilia B in Korean population.
Diagnosis* ; DNA* ; Factor IX* ; Hemophilia A* ; Hemophilia B* ; Humans ; Molecular Biology* ; Parents ; Polymerase Chain Reaction ; Prenatal Diagnosis ; Restriction Mapping

No abstract available.
Spine*

No abstract available.
Mucocele*

PURPOSE: The insulin-like growth factor-I receptor (IGF-IR) is a member of the transmembrane tyrosine kinase family that regulates various biological processes. These processes include maintaining optimal cell growth, establishing and maintaining the transformed phenotype, tumorigenesis for several types of cells, and antiapoptosis. This study investigated the immunohistochemical expression of IGF-IR in relation with the expression of the estrogen receptor (ER), the progesteron receptor (PR), proliferative activity (Ki-67) as well as with the other conventional clinicopathlogical parameters in breast cancer. METHODS: This study was performed on paraffin sections from 64 invasive ductal breast carcinoma specimens by immunohistochemistry using rabbit polyclonal antibodies to the IGF-I receptor. RESULTS: IGF-IR expression was detected in 56 (87.5%) cases. The immunohistochemical stains for the IGF-IR were scored according to a semi quantitative scoring system. IGF-IR staining was positively correlated with the ER status, but not significantly with the PR, lymph node status, tumor size, histological grade, and proliferative activity. The Ki-67 labeling index showed a significant correlation with the tumor grade and ER status. CONCLUSION: The IGF-IR may play a role in estrogen-mediated growth and the pathogenesis of breast cancer.
Antibodies ; Biological Processes ; Breast Neoplasms ; Breast* ; Carcinogenesis ; Carcinoma, Ductal* ; Coloring Agents ; Estrogens ; Humans ; Immunohistochemistry ; Lymph Nodes ; Paraffin ; Phenotype ; Protein-Tyrosine Kinases ; Receptor, IGF Type 1

BACKGROUND: The aim of this trial was to evaluate the acetazolamide induced vasoreactivity of the cerebral vasculature in patients with carotid stenosis/occlusion, relative changes of blood flow velocity within the middle cerebral artery were measured by transcranial doppler ultrasonography during acetazolamide challenge. To evaluate the effectiveness of extracranial-intracranial bypass surgery in patients with ICA stenosis/occlusion with decreased vasoreactivity, we studied whether the vasoreactivity could show a significant difference between the territorial infarction and borderzone infarction cases. METHODS: To test vasoreactivity in 21 patients with unilateral carotid stenosis or occlusion, we measured blood flow velocity in the middle cerebral artery by transcranial doppler sonography both at rest and after injection of acetazolamide. Among 21 patients, 13 patients are MCA territorial and 8 patients are borderzone infarction which are angiographically confirmed symptomatic cases. RESULTS: The increase in blood flow velocity (%Vm) after acetazolamide stimulation was significantly different between the both hemisphere (affected side: 24.01+/-24.44%, contralateral side: 49.39+/-19.38%, p<0.05). In patients with carotid stenosis/occlusion, vasoreactivity of the borderzone infarction cases was lower than territorial infarction cases(mean+/-SD: 12.25+/-11.20% and 29.92+/-26.42%, p=0.13), but it is not significant statistically. CONCLUSION: We concluded that TCD with acetazolamide challenge is a useful method for assessment of the adequacy of hemodynamic reserve in patients with severe stenosis or occlusive cerebrovascular disease but it is very difficult problem apply to EC-IC bypass surgery directly.
Acetazolamide* ; Blood Flow Velocity ; Carotid Stenosis* ; Constriction, Pathologic ; Hemodynamics ; Humans ; Infarction ; Middle Cerebral Artery ; Ultrasonography, Doppler, Transcranial